Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 21 May 2009, doi:10.1136/bmj.b1574
Cite this as: BMJ 2009;338:b1574
Karen E A Burns, clinical scientist, scientist, assistant professor of medicine1,2,3, Neill K J Adhikari, intensivist, associate scientist, lecturer4,5,6, Sean P Keenan, head, clinical assistant professor of medicine7,8, Maureen Meade, associate professor of medicine9
1 Interdepartmental Division of Critical Care, St Michaels Hospital, Toronto, ON, Canada M5B 1W8, 2 Keenan Research Centre, Li Ka Shing Knowledge Institute, Toronto, ON, Canada, 3 Divisions of Respiratory and Critical Care Medicine, University of Toronto, Toronto, ON, Canada, 4 Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 5 Sunnybrook Research Institute, Toronto, ON, 6 Interdepartmental Division of Critical Care, University of Toronto, Toronto,d ON, 7 Department of Critical Care, Royal Columbian Hospital, New Westminster, BC, 8 Division of Critical Care Medicine, Department of Medicine, Vancouver, BC, 9 Department of Clinical Epidemiology and Biostatics, McMaster University, Hamilton, ON
Correspondence to: K E A Burns Burnsk{at}smh.toronto.on.ca
Design Systematic review and meta-analysis of randomised and quasi-randomised controlled trials.
Setting Intensive care units.
Participants Critically ill adults receiving invasive ventilation.
Study selection criteria We searched Medline, Embase, and CENTRAL, proceedings from four conferences, and reference lists of relevant studies to identify relevant trials. Two reviewers independently selected trials, assessed trial quality, and abstracted data.
Results We identified 12 trials enrolling 530 participants, mostly with chronic obstructive pulmonary disease. Compared with invasive weaning, non-invasive weaning was significantly associated with reduced mortality (relative risk 0.55, 95% confidence interval 0.38 to 0.79), ventilator associated pneumonia (0.29, 95% 0.19 to 0.45), length of stay in intensive care unit (weighted mean difference –6.27 days, –8.77 to –3.78) and hospital (–7.19 days, –10.80 to –3.58), total duration of ventilation, and duration of invasive ventilation. Non-invasive weaning had no effect on weaning failures or weaning time. Benefits on mortality and weaning failures were non-significantly greater in trials that exclusively enrolled patients with chronic obstructive pulmonary disease versus mixed populations.
Conclusions Current trials in critically ill adults show a consistent positive effect of non-invasive weaning on mortality and ventilator associated pneumonia, though the net clinical benefits remain to be fully elucidated. Non-invasive ventilation should preferentially be used in patients with chronic obstructive pulmonary disease in a highly monitored environment.
© Burns et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses